The Bioquell PLC Board

Nigel Keen, FCA

Non-executive Chairman, joined the Board in March 2008. He gained a degree in Engineering from Cambridge University and also qualified as an accountant with Deloittes. He has pursued a career encompassing industry, venture capital and banking. In 1984 Nigel Keen founded the Cygnus group of venture capital investment companies. Cygnus provides finance and management skills to emergent, developing and mature companies with high growth potential.

He is the chairman of a number of high growth publicly listed companies, including the Laird Group PLC, Axis-Shield PLC, Oxford Instruments PLC and Deltex Medical Group PLC.

Nicholas Adams

Chief Executive, joined the Board in May 1997 and was appointed Chief Executive in May 1998. Previously he was a Director of Corporate Finances at Barings, having spent nine years in Barings' Corporate Finance Department both in the UK and continental Europe. He read Chemistry at Durham University.
 

Mark Bodeker, CA

Chief Operating Officer and Chief Financial Officer, joined the Board in April 2000. He qualified with and subsequently worked for Deloitte Haskins and Sells for five years before moving to TI Group, holding a number of financial positions. Latterly he was divisional finance director of Meggitt Aerospace Components.

Simon Constantine, ACA

Non-Executive Director, joined the Board in November 1999. Previously he had held a number of financial and operational positions at Board level within Life Sciences International PLC. He is also a non-executive director of Sterigenics Holdings, Inc, Xema Systems Ltd, and Capstone Foster Care Ltd.

Sir Ian Carruthers, OBE

Non-executive Director, joined the Board in August 2010. He is Chief Executive of the South West Strategic Health Authority and has extensive experience of the UK and international healthcare systems.

Tony Bourne

Non-executive Director, joined the Board on 24 March 2009. He is Chief Executive of the British Medical Association. Previously he held senior positions at the investment banks Paribas and Merrill Lynch.

Christopher Mills

Non-executive Director, joined the Board in December 2012. He is the Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust PLC, a director of Oryx International Growth Fund Limited  and is the Chief Investment Officer, and a member, of Harwood Capital LLP.